Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Shanghai Anovent Closes Funding Led by Sequoia for Respiratory Drugs

publication date: Nov 13, 2019

Shanghai Anovent Pharma closed a new funding led by Sequoia China to support its portfolio of next-gen, high-quality, efficient, safe and affordable inhalation medicines that include generic and innovative pharmaceuticals. The amount of the financing was not disclosed. The company has applied for several patents to protect its soft mist inhalation technology, which has been recognized for its innovation. Founded in 2014, Anovent plans to offer inhalation products that will serve markets with $20 billion of annual revenues globally. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital